There is good news about the vaccine being made for the corona virus. The Union Health Ministry has allowed the Pune-based Genova company to undergo human testing for its vaccines. It is the first such vaccine in the country that has been given such approval. Explain that this vaccine has been developed based on the messenger-RNA i.e. mRNA technology. Such vaccines use messenger RNA, which tells the body what type of protein to make.
Prior to Jinova, the Pfizer and Moderna Company have completed human trials. Moderna’s vaccine is said to be 94.5 percent effective and Pfizer’s vaccine up to 90 percent effective. Both of these have also been developed using the basis of Vaccine Messenger-RNA.
The Drugs Controller General of India (DCGI) has given conditional approval for the first and second phase clinical trials of India’s first mRNA Covid-19 Vaccine Candidate -HGCO19-. It is being manufactured by Genova Biopharmaceuticals.
Genova Biopharmaceuticals is a Pune-based firm working with HDT Biotech Corporation (USA) to develop the vaccine. Conditional approval for human testing was granted following the recommendation of the expert committee.
The committee of experts has said that the Serum Institute and Bharat Biotech will have to wait a little longer for the corona vaccine. They need to collect more data. While the third company Pfizer Company has asked for more time for its presentation.
The Subject Expert Committee (SEC) also held a meeting to allow the emergency use of the EUA. In the same meeting, the SEC has suggested the Serum Institute and Bharat Biotech to collect data before allowing for the emergency use of vaccines in India.